Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [4]
- ELISA [1]
- Immunoprecipitation [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN393423 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1) (AA 1-481) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Epitope
- AA 1-481
- Isotype
- IgG
- Antibody clone number
- 2E11
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer.
HER-2/AKT expression in upper urinary tract urothelial carcinoma: prognostic implications.
miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells.
Slattery ML, Herrick JS, Lundgreen A, Fitzpatrick FA, Curtin K, Wolff RK
Carcinogenesis 2010 Sep;31(9):1604-11
Carcinogenesis 2010 Sep;31(9):1604-11
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer.
Benesch C, Schneider C, Voelker HU, Kapp M, Caffier H, Krockenberger M, Dietl J, Kammerer U, Schmidt M
Anticancer research 2010 May;30(5):1689-94
Anticancer research 2010 May;30(5):1689-94
HER-2/AKT expression in upper urinary tract urothelial carcinoma: prognostic implications.
Izquierdo L, Truan D, Mengual L, Mallofré C, Alcaraz A
Anticancer research 2010 Jun;30(6):2439-45
Anticancer research 2010 Jun;30(6):2439-45
miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells.
Lin RJ, Lin YC, Yu AL
Molecular carcinogenesis 2010 Aug;49(8):719-27
Molecular carcinogenesis 2010 Aug;49(8):719-27
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC